These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 43488)

  • 21. [Treatment with Pharmachim's Chlophazolin of hypertension and symptomatic hypertonia].
    Koĭchev A; Belovezhdov N; Chakŭrski I; Stefanov G; Angelova I
    Vutr Boles; 1986; 25(1):72-7. PubMed ID: 2872753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
    Bühler FR
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1798-806. PubMed ID: 13490
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy.
    Lubbe WF; Hodge JV
    N Z Med J; 1981 Sep; 94(691):169-72. PubMed ID: 6117042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diovan effectiveness in combined treatment of severe arterial hypertension].
    Bichan NA; Maslov AP
    Ter Arkh; 2000; 72(8):34-6. PubMed ID: 11019424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations on physiopathological approaches to the treatment of hypertension.
    Zanchetti A; Leonetti G; Morganti A; Terzoli L
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension].
    Olmer M; Ducros J; Grandvuillemin M; Salvadori JM
    Sem Hop; 1977 May; 53(20):1147-53. PubMed ID: 20666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-adrenergic receptor blocking drugs in hypertension.
    Simpson FO
    Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
    Grüninger U; Akert R; Hunkeler H; Wegmüller E; Weidmann P; Hodler J
    Klin Wochenschr; 1979 Jul; 57(14):731-9. PubMed ID: 470335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
    Davies R; Payne NN; Slater JD
    Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Effects of beta-adrenergic blockade with propranolol.
    N Engl J Med; 1975 Apr; 292(14):755-6. PubMed ID: 234594
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prospects of beta-blocking treatment in arterial hypertension].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):573-8. PubMed ID: 45049
    [No Abstract]   [Full Text] [Related]  

  • 39. [The potential of beta-blockaders in the management of hypertension].
    Bühler FR; Kowski W; Bolli P; Bertel O
    Internist (Berl); 1978 Sep; 19(9):510-9. PubMed ID: 29849
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha- and beta-adrenergic receptor blocking agents combined with a diuretic in the treatment of essential hypertension.
    Vlachakis ND; Mendlowitz M
    J Clin Pharmacol; 1976 Jul; 16(7):352-60. PubMed ID: 7576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.